Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic

JAMA Oncol. 2020 Sep 1;6(9):1326-1327. doi: 10.1001/jamaoncol.2020.2370.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Betacoronavirus / pathogenicity
  • COVID-19
  • Clinical Trials as Topic
  • Coronavirus Infections / complications
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / virology
  • Humans
  • Medical Oncology / trends
  • Neoplasms / complications
  • Neoplasms / epidemiology*
  • Neoplasms / virology
  • Pandemics*
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / virology
  • SARS-CoV-2